drugset / Trial / NCT02144389
Arachidonic Acid Treatment Against Schistosomiasis Infection in Children
Completed
335 enrolled
dsm-firmenich Switzerland AG
Cairo University · collabHigh Institute of Public Health, Egypt · collabNational Liver Institute, Egypt · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Randomized Controlled Trial: The investigational materials used in this trial were administered to subjects each day by trained clinicians. Primary Objectives: * assess the effect of dietary supplementation with arachidonic acid on the cure rates for Schistosomiasis mansoni with and without concomitant treatment with praziquantel. * assess the safety of dietary supplementation using arachidonic acid in children with clinically confirmed schistosomiasis mansoni infection. Secondary objective: * to measure changes in total phospholipids in plasma.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-07
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Praziquantel | Small molecule | 40 mg/kg | Oral |